| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 653.602.831 $ | +258.432.623 $ | +97,9 % | 443.451.290 $ | -237.661.681 $ | -25,1 % | 1.201.945.240 $ | +617.720.577 $ | +144,5 % | |
| ARK Investment Management LLC | 186.008.545 $ | +58.284.705 $ | +45,6 % | 127.723.840 $ | -78.120.360 $ | -38,0 % | 205.844.200 $ | +83.736.525 $ | +68,6 % |
| VANGUARD GROUP INC | 116.959.909 $ | -73.784.131 $ | -38,7 % | 190.744.040 $ | +88.950.694 $ | +87,4 % | |||
| BlackRock, Inc. | 155.837.437 $ | +63.448.567 $ | +68,7 % | 92.388.870 $ | -67.804.485 $ | -42,3 % | 160.193.355 $ | +66.138.456 $ | +70,3 % |
| MORGAN STANLEY | 104.009.912 $ | +65.393.752 $ | +169,3 % | ||||||
| Contrarius Group Holdings Ltd | 101.719.195 $ | +87.156.670 $ | +598,5 % | ||||||
| STATE STREET CORP | 88.748.706 $ | +31.043.370 $ | +53,8 % | 57.705.336 $ | -28.141.572 $ | -32,8 % | 85.846.908 $ | +47.958.415 $ | +126,6 % |
| GOLDMAN SACHS GROUP INC | 73.892.752 $ | +54.385.654 $ | +278,8 % | ||||||
| D. E. Shaw & Co., Inc. | 73.435.230 $ | +24.761.895 $ | +50,9 % | 48.673.335 $ | +10.188.867 $ | +26,5 % | |||
| REGENERON PHARMACEUTICALS, INC. | 47.472.396 $ | +14.182.471 $ | +42,6 % | 63.950.724 $ | +29.216.631 $ | +84,1 % | |||
| TWO SIGMA INVESTMENTS, LP | 60.329.651 $ | +36.067.996 $ | +148,7 % | 42.304.713 $ | +20.950.449 $ | +98,1 % | |||
| BAKER BROS. ADVISORS LP | 47.435.060 $ | +22.337.238 $ | +89,0 % | ||||||
| GEODE CAPITAL MANAGEMENT, LLC | 44.714.752 $ | +20.265.970 $ | +82,9 % | ||||||
| UBS Group AG | 41.770.866 $ | +30.643.619 $ | +275,4 % | ||||||
| Sumitomo Mitsui Trust Group, Inc. | 40.668.363 $ | +15.611.897 $ | +62,3 % | ||||||
| Amova Asset Management Americas, Inc. | 40.621.266 $ | +15.618.226 $ | +62,5 % | ||||||
| 653.602.831 $ | +258.432.623 $ | +97,9 % | 443.451.290 $ | -237.661.681 $ | -25,1 % | 1.201.945.240 $ | +617.720.577 $ | +144,5 % | |